Literature DB >> 32579958

Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseases.

Fernanda C Cardoso1.   

Abstract

Venom peptides are amongst the most exquisite group of bioactive molecules able to alter the normal physiology of organisms. These bioactive peptides penetrate tissues and blood vessels to encounter a number of receptors and ion channels to which they bind with high affinity and execute modulatory activities. Arachnid is the most diverse class of venomous animals often rich in peptides modulating voltage-gated sodium (NaV), calcium (CaV), and potassium (KV) channels. Spider venoms, in particular, contain potent and selective peptides targeting these channels, with a few displaying interesting multi-target properties for NaV and CaV channels underlying disease mechanisms such as in neuropathic pain, motor neuron disease and cancer. The elucidation of the pharmacology and structure-function properties of these venom peptides are invaluable for the development of effective drugs targeting NaV and CaV channels. This perspective discusses spider venom peptides displaying multi-target properties to modulate NaV and CaV channels in regard to their pharmacological features, structure-function relationships and potential to become the next generation of effective drugs to treat neurological disorders and other multi-ion channels related diseases.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diseases; Ion channels; Multi-target; Spider venom; Therapies; Venom peptides

Year:  2020        PMID: 32579958     DOI: 10.1016/j.bcp.2020.114107

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Venom-Derived Peptides Inhibiting Voltage-Gated Sodium and Calcium Channels in Mammalian Sensory Neurons.

Authors:  Arsalan Yousuf; Mahsa Sadeghi; David J Adams
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Editorial: Venom Peptides: A Rich Combinatorial Library for Drug Development.

Authors:  Fernanda C Cardoso; Denis Servent; Maria Elena de Lima
Journal:  Front Mol Biosci       Date:  2022-05-13

3.  The Tarantula Toxin ω-Avsp1a Specifically Inhibits Human CaV3.1 and CaV3.3 via the Extracellular S3-S4 Loop of the Domain 1 Voltage-Sensor.

Authors:  Volker Herzig; Yong-Cyuan Chen; Yanni K-Y Chin; Zoltan Dekan; Yu-Wang Chang; Hui-Ming Yu; Paul F Alewood; Chien-Chang Chen; Glenn F King
Journal:  Biomedicines       Date:  2022-05-04

Review 4.  Novel Therapies for the Treatment of Neuropathic Pain: Potential and Pitfalls.

Authors:  Pottathil Shinu; Mohamed A Morsy; Anroop B Nair; Abdulaziz K Al Mouslem; Katharigatta N Venugopala; Manoj Goyal; Monika Bansal; Shery Jacob; Pran Kishore Deb
Journal:  J Clin Med       Date:  2022-05-26       Impact factor: 4.964

5.  Interactions of Sea Anemone Toxins with Insect Sodium Channel-Insights from Electrophysiology and Molecular Docking Studies.

Authors:  Beata Niklas; Milena Jankowska; Dalia Gordon; László Béress; Maria Stankiewicz; Wieslaw Nowak
Journal:  Molecules       Date:  2021-02-28       Impact factor: 4.411

6.  Multitarget nociceptor sensitization by a promiscuous peptide from the venom of the King Baboon spider.

Authors:  Rocio K Finol-Urdaneta; Rebekah Ziegman; Zoltan Dekan; Jeffrey R McArthur; Stewart Heitmann; Karen Luna-Ramirez; Han-Shen Tae; Alexander Mueller; Hana Starobova; Yanni K-Y Chin; Joshua S Wingerd; Eivind A B Undheim; Ben Cristofori-Armstrong; Adam P Hill; Volker Herzig; Glenn F King; Irina Vetter; Lachlan D Rash; David J Adams; Paul F Alewood
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-01       Impact factor: 12.779

Review 7.  Peripheral Voltage-Gated Cation Channels in Neuropathic Pain and Their Potential as Therapeutic Targets.

Authors:  Sascha R A Alles; Peter A Smith
Journal:  Front Pain Res (Lausanne)       Date:  2021-12-13

8.  Toxinologic and Pharmacological Investigation of Venomous Arthropods.

Authors:  Gandhi Rádis-Baptista; Katsuhiro Konno
Journal:  Toxins (Basel)       Date:  2022-04-15       Impact factor: 5.075

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.